Co-Founder

H1

Ariel started his first company in college, ResearchConnection, to help connect students with research opportunities. That company grew to over 40 universities and was eventually acquired by the Bill and Melinda Gates Foundation and the Ewing Kauffman Foundation. Next Ariel started two new ventures, one was to help track scholarly output of medical students, Labspot, and the other was a joint venture with Shore Group to collect data to help scientists at universities make decisions. Shore Group, acquired both Labspot and GreenSight. H1 then started. H1, led by Ariel, is a platform of every doctor globally used by the healthcare community to improve the way it develops drugs and devices.

Latest insights

Fri Mar 13 2020

Did an experimental drug help a U.S. coronavirus patient?

Fri Jan 10 2020

MoneyBall Medicine: Tom Davenport on the Analytics Gap in Healthcare

Wed Dec 18 2019

MoneyBall Medicine – Milind Kamkolkar on Seeing the Forest and the Tr...

Fri Nov 8 2019

Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery

Never miss an announcement